RG
CBIO

Redmile Group’s Crescent Biopharma CBIO Stock Holding History

Redmile Group’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,535
Closed -$578K – 83
2020
Q1 		$578K Sell
2,535
-10,903
-81% -$4.17M 0.02% 65
2019
Q4 		$7.11M Sell
13,438
-6,538
-33% -$3.54M 0.17% 57
2019
Q3 		$8.61M Sell
19,976
-108
-0.5% -$69.5K 0.29% 55
2019
Q2 		$23.9M Sell
20,084
-98
-0.5% -$117K 0.68% 45
2019
Q1 		$25.1M Buy
20,182
+397
+2% +$455K 0.74% 41
2018
Q4 		$18.7M Sell
19,785
-696
-3% -$838K 0.75% 42
2018
Q3 		$29.5M Buy
20,481
+188
+0.9% +$284K 0.91% 41
2018
Q2 		$32.7M Sell
20,293
-2,530
-11% -$4.35M 1.11% 32
2018
Q1 		$37M Buy
22,823
+3,516
+18% +$7.31M 1.43% 27
2017
Q4 		$32.4M Buy
19,307
+7,166
+59% +$9.48M 1.41% 25
2017
Q3 		$17M Buy
12,141
+6,145
+102% +$7.21M 0.84% 36
2017
Q2 		$6.69M Buy
+5,996
New +$4.95M 0.41% 49

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return